Latest AI and machine learning research in allergy for healthcare professionals.
The tumor immune microenvironment and intratumoral microbiota play critical roles in cancer progress...
CLINICAL/METHODICAL ISSUE: Eosinophilic pneumonias are rare inflammatory lung diseases with heteroge...
BACKGROUND AND OBJECTIVES: Nonsteroidal anti-inflammatory drugs (NSAIDs) are the main triggers of dr...
Elastin-like polypeptides (ELPs), inspired by the natural elasticity of human elastin, are rapidly e...
In the last decades, critical advancements in research technology and knowledge on disease mechanism...
Hyperuricemia is a well-established direct trigger of gouty arthritis. Xanthine oxidase (XO), the ra...
BACKGROUND: The Dutch flagship project Next Generation ImmunoDermatology (NGID) aims to profile five...
PURPOSE: Programmed cell death ligand-1 (PD-L1) is a key prognostic and predictive biomarker for imm...
Cancer immunotherapies trigger highly variable responses in patients and in genetically identical mo...
T cells are central to the adaptive immune response, capable of detecting pathogenic antigens while ...
This review examines how biotechnology advances (CRISPR/Cas9, next-generation targeted therapies, na...
Esophageal squamous cell carcinoma (ESCC) remains a major health burden, particularly in Asia, with ...
Hepatocellular carcinoma (HCC), the predominant form of primary liver cancer, ranks as the fourth le...
Tumor Mutational Burden (TMB) is a widely used biomarker for selecting cancer patients for immune ch...
Immune checkpoint inhibitors (ICI) have improved clinical outcomes for some patients with advanced N...
This study systematically predicts prognosis and key gene targets for immunotherapy in hepatocellula...
OBJECTIVES: Urbanization-related air pollution may be associated with olfactory dysfunction (OD) in ...
The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small c...
PURPOSE: Endoscopically identifying eosinophilic esophagitis (EoE) is difficult due to its rare inci...
The discovery of natural killer (NK) cells stands among the fundamental milestones in modern immunol...
Recent advancements in cancer immunotherapy have transformed clinical oncology, with monoclonal anti...